The store will not work correctly when cookies are disabled.
4'-(2-Butoxyethoxy)-2',5'-dimethyl[1,1'-biphenyl]-4-carboxylic acid
ID: ALA469322
Cas Number: 920269-85-8
PubChem CID: 15952020
Max Phase: Preclinical
Molecular Formula: C21H26O4
Molecular Weight: 342.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCOCCOc1cc(C)c(-c2ccc(C(=O)O)cc2)cc1C
Standard InChI: InChI=1S/C21H26O4/c1-4-5-10-24-11-12-25-20-14-15(2)19(13-16(20)3)17-6-8-18(9-7-17)21(22)23/h6-9,13-14H,4-5,10-12H2,1-3H3,(H,22,23)
Standard InChI Key: NQETXGPFDKYFOG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.3731 -10.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0906 -10.6469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8027 -10.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7973 -9.4074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0820 -8.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3699 -9.4178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6610 -10.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9458 -10.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2378 -10.6641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2409 -11.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9542 -11.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6663 -11.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5094 -8.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5062 -8.1673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2268 -9.4007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5289 -11.9041 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8136 -11.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1015 -11.9145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6160 -11.5030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3280 -11.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0454 -11.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7575 -11.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4708 -11.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3836 -11.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5214 -10.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
1 7 1 0
13 14 2 0
13 15 1 0
4 13 1 0
17 18 1 0
16 17 1 0
20 21 1 0
21 22 1 0
22 23 1 0
19 20 1 0
18 19 1 0
10 16 1 0
12 24 1 0
9 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.44 | Molecular Weight (Monoisotopic): 342.1831 | AlogP: 4.86 | #Rotatable Bonds: 9 |
Polar Surface Area: 55.76 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.08 | CX Basic pKa: ┄ | CX LogP: 5.42 | CX LogD: 2.31 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.66 | Np Likeness Score: -0.43 |
References
1. Lund BW, Knapp AE, Piu F, Gauthier NK, Begtrup M, Hacksell U, Olsson R.. (2009) Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands., 52 (6): [PMID:19239230] [10.1021/jm801532e] |